It took almost 20 years to recognize that the responses and outcomes from the variable-wavelength therapy are "merely" the body returning to its normal functioning and improved wellness.
The years and $$ invested led to IP that may be reused. The Instant Verification System and its creating team can customize the System for internal needs and to support researchers who may wish to explore any of the unpredicted events that were recorded in real time.
2000 - 2018 The therapy had to be interrupted to change settings via templates and express user selections.
2018+ The battery-powered Varichrome™ Pro enables the user to dynamically adjust the output during therapy via pre-programmed selections or by manually adjusting wavelength and frequency.
2000 - First prototype with manual wavelength selection - The new therapy prompted resolution of a Morton's neuroma during the first session.
2001 - Computer that controlled and recorded the wavelength emitted as it varied during therapy.
2001 - 2002 Early data collection using sEMG in real-time during therapy in a study of trapezius spams.
2001 - 2007 - Tested various confirgurations but found that multiple simultaneous wavelengths did not appear to improve therapeutic efficiency
2001 - 2007 - The prototype documenting system evolved along with the therapy, a touchscreen user interface let the practitioner describe where the therapy was being applied. Questionnaires and other modules were added. Later versions would be called the Instant Verification System.
2005 - 2007 - The System included a reduced the size of the light emitting modules. A Doppler blood flow meter confirmed an increase in blood circulation when abnormally cold hands resumed normal functioning.
2006 - 2007 - This System was used in an IRB study that confirmed that red wavelengths are NOT a requirement for relieving diabetic neuropathy and that skin color doesn't appear to limit the variable-wavelength therapy. 28 subjects with dark skin participated. The all-electronic data set was a first for the statistician. A Doppler blood flow meter confirmed an increase in blood circulation when abnormally cold hands resumed normal functioning. A Raytheon thermal imaging camera (housed in the black box) was used to record changes in skin temperature, but lacked stability.
2006 - 2011 - The Photon Delivery System evolved to include a second monitor to observe data from multiple sources Several of the light source modules operated in the field for more than 10 years before being retired. A FLIR thermal imaging camera provided data that was improved vs. the Raytheon camera, but a recalibration process every 5 minutes introduced challenges for detecting small changes in temperature during a 30-60 minute period.
2010 - 2017 - The Photon Delivery System software moved to a laptop. An ICI thermal imaging camera provided adequate stability for measuring small changes in temperature during a 30-60 minute visit. Thermal imaging provided information for disorders with abnormal thermoregulation. The user interface capability was expanded to document changes in multiple sites of pain during a single visit . One system operated without a failure for over 4 years in an IRB reviewed study in Sacramento, CA. More than 400 volunteers enrolled with "nothing works" chronic pain, impaired functioning, and/or non-healing wounds.
2017 - A multiple camera setup in the Instant Verification System for documenting effects during treatments.
2018 - 2020 First Vari-Chrome Pro prototype introduced during therapy adjustment of treatment parameters. FDA exempted photobiomodulation devices for improving wellness. PhotoMed's data suggests that the return to normal functioning better describes wellness than "managing" and maintaining a preferred abnormality such as masking pain.
2020 Field testing of the Varichrome™ Pro suggested ergonomic improvements. Battery power was added to Varichrome Pro prototype and added the ability to vary the rate of variation during therapy.